Mucoid Pseudomonas aeruginosa colonizes and infects the respiratory tract of most older patients with cystic fibrosis. These bacteria resist both opsonin-dependent and -independent phagocytosis by human polymorphonuclear leukocytes and monocyte-derived macrophages. Resistance to phagocytosis is thought to be mediated in part by the mucoid exopolysaccharide associated with the bacterial surface. The purpose of this study was to determine whether degradation of the mucoid exopolysaccharide by alginase enhances bacterial susceptibility to nonopsonic phagocytosis by macrophages. Eight phagocytosis-resistant mucoid P. aeruginosa isolates from patients with cystic fibrosis were studied. The bacteria were treated with a preparation of alginase from Bacillus circulans, and phagocytosis by macrophages was measured by a visual inspection assay. Alginase degradation of mucoid exopolysaccharide was measured by the periodate-thiobarbituric acid assay and by indirect immunofluorescence with a mouse monoclonal antibody to the mucoid exopolysaccharide. Alginase degraded the mucoid exopolysaccharide of all eight mucoid strains tested. Phagocytosis was enhanced in five of the eight strains. Alginase-enhanced phagocytosis was magnesium dependent and heat labile. Alginase may be a useful tool for studying the biological properties of P. aeruginosa mucoid exopolysaccharide.
Mucoid strains of Pseudomonas aeruginosa frequently colonize the respiratory tract of older patients with cystic fibrosis (CF). The resulting chronic infection is the major contributing factor to morbidity and mortality in these patients (19) . Mucoid P. aeruginosa resists both nonopsonic phagocytosis by human monocyte-derived macrophages (MO) and by neutrophils (3) and opsonic phagocytosis by neutrophils in the absence of specific antibody (1) . The mucoid exopolysaccharide (MEP) of mucoid P. aeruginosa enhances adherence of this organism to tracheal epithelial cells (21) , and MEP from some mucoid strains binds to both human buccal and tracheal epithelial cells (6) . All efforts to eradicate mucoid P. aeruginosa from infected lungs of CF patients have been unsuccessful. In this paper we propose the use of the enzyme alginase as a tool to study the role of bacterial alginate in resistance of mucoid P. aeruginosa to nonopsonic phagocytosis by M+.
Alginases or alginate-degrading enzymes are produced by a number of environmental organisms, including marine bacteria, algae, and marine mollusks (5, 7, 13, 27, 28) . Other gram-negative bacteria such as Azotobacter vinelandii (12) (and a bacteriophage specific for A. vinelandii [4] ), Klebsiella aerogenes (2) , Pseudomonas maltophilia and Pseudomonas putida (28, 29) , and P. aeruginosa (8, 15) have also been reported to produce alginases. Hansen et al. (10, 11) isolated an extracellular alginase from strains of Bacillus circulans. Not all of the reported alginases have been extensively studied, but those which have been characterized seem to be capable of degrading both bacterial and/or algal alginates and partially hydrolyzed polyuronic acid substrates (4, 5, 7, 8, 10, 15, 28, 29) . Alginates are polyuronic acid complexes composed of 1,4-linked D-mannuronic and L-guluronic acids. Bacterial alginates are distinguished from algal polymers by possession of 0-acetyl groups, mainly on their mannuronate blocks (9, 16, 22, 23) . A well-character-* Corresponding author.
ized bacterial alginate is the MEP elaborated in large quantities by mucoid strains of P. aeruginosa which colonize the lungs of older CF patients. The purpose of this study was to determine whether an alginase from B. circulans could degrade MEP from the surface of mucoid P. aeruginosa and render the bacteria susceptible to nonopsonic phagocytosis by M+. (20) . Alginase activity was also assayed by measuring the increase of optical density at 235 nm, which assesses formation of unsaturated uronic acids of the intermediate oligosaccharides (20) . The (9) , as described previously (24) .
MATERIALS AND METHODS
Alginase treatment of mucoid P. aeruginosa strains. Mucoid P. aeruginosa isolates from CF patients were grown on Trypticase soy agar plates directly from frozen cultures (37°C for 24 h). The bacteria were swabbed from the plates, suspended in Tris, washed twice, and adjusted spectrophotometrically to 109 bacteria per ml. The bacterial suspension was incubated with alginase (125 U/ml; specific activity, 7.7), heat-inactivated (60°C for 2 h) alginase, or Tris at 37°C with rotation. Depending on the experiment, the total volume varied between 300 and 500 ,ul. In some experiments, enzyme treatment of bacteria and other control treatments were carried out in the presence of various amounts of Mg2 . Samples were removed at various time intervals and centrifuged. The supernatants were tested by the TBA assay for enzyme activity, and the bacteria were suspended in RPMI 1640 at a concentration of 109/ml.
Indirect immunofluorescence of mucoid P. aeruginosa before and after alginase treatment. Immunofluorescence of mucoid P. aeruginosa was determined as described by Mutharia and Hancock (18) . Briefly, P. aeruginosa suspensions treated with alginase, heat-inactivated alginase, or Tris were smeared on glass slides, air dried, and heat fixed. A mouse monoclonal antibody to MEP (a gift from G. Pier, Harvard University, Boston, Mass.) was diluted (1:100) in PBS (pH 7.4) with 1% fetal calf serum (PBS/FCS). The smears were incubated with the monoclonal antibody or PBS at room temperature for 30 min and washed three times with PBS/FCS. Fluoresceinated anti-mouse immunoglobulin G (Organon Teknika, Malvern, Pa.) was added to each smear at a dilution of 1:20, and the slides were incubated at room temperature for another 30 min. The slides were washed four times with PBS/FCS, air dried, and examined with a Zeiss epifluorescence microscope. The intensity of fluorescence was graded as 0 to 4+.
Preparation of M+. M4were prepared from human mononuclear cells as previously described (26) . Cultured monocytes in Teflon beakers were used after 4 to 7 days of in vitro maturation.
Phagocytosis. Phagocytosis of unopsonized P. aeruginosa was performed as described previously (25) with M4 adherent to glass coverslips. Suspensions of 107 to 108 mucoid bacteria treated with alginase, heat-treated alginase, or Tris (0.1 ml) were added to each well of a 24-well tissue culture plate (Becton Dickinson Labware, Oxnard, Calif.) containing a glass coverslip on which M4had been plated in a total volume of 1 ml. The plates were incubated at 37°C in 5% CO2 with gentle rocking for 1 h, and phagocytosis was then assessed visually by light microscopy. In some experiments, alginase was directly added to the phagocytic mixture in the tissue culture plate wells and bacteria were not preincubated with the enzyme. A total of 100 M( were examined for each test condition, and the number of bacteria per M4 was recorded.
Statistical analysis. Differences between conditions (bacteria treated with alginase, heat-inactivated alginase, or Tris) were analyzed by analysis of variance to allow for day-today variation. All hypotheses were based on the standard error estimates obtained from the analysis of variance. The significance of differences between conditions is reported.
RESULTS
Isolation and partial purification of alginase. The crude alginase extract was prepared from the supernatant of 72-h batch cultures of B. circulans by 70% ammonium sulfate precipitation (Fig. 1, lane 1 Table 2 . A Mg2+ concentration of 2 mM resulted in the greatest bacterial uptake with 7-day-old M+. In general, the 4-day-old M4 had lower uptake compared with that by older M+, and the optimum Mg2+ concentration was 2 to 5 mM. A Mg2+ concentration of 2 mM was therefore used for alginase treatment of all eight mucoid strains.
Effect of alginase treatment on different mucoid P. aeruginosa strains. Eight mucoid strains of P. aeruginosa which were resistant to phagocytosis by M4 were used (Table 3) . Each strain was studied on multiple days with M4X from different donors. The mean values and standard errors were calculated and compared for different conditions, using analysis of variance to adjust for day-to-day variation. Phagocytosis of strains C1712M, C1628M, C1900M, LM3M, and C2141M was enhanced after pretreatment of bacteria with alginase compared with pretreatment with Tris (P < 0.0001 for each of the five strains). Heat-inactivated alginase enhanced bacterial uptake compared with that by Tris controls, but the increase was significantly less than that obtained with native alginase (P < 0.0001). Strains C2101M, C2146M, and C2208M were not phagocytosed by M( under any experimental condition and were classified as "non- Table 4 . Only the native enzyme enhanced bacterial uptake by M+~, and heat-inactivated alginase had no effect on phagocytosis. Both crude and partially purified alginase enhanced phagocytosis of strain C1900M to the same extent ( Table 4) .
The results of the TBA assay performed on the supernatants of bacteria treated with alginase, heat-inactivated alginase, or Tris buffer are shown in Table 5 . The presence of TBA-positive material, measured by an increase of optical density at 549 nm, was observed only when the organisms Immunofluorescence of alginase4treated bacteria. The effect of alginase on three mucoid P. aeruginosa strains was measured by indirect immunofluorescence, using a monoclonal antibody to MEP (Table 6 ). All three strains showed intense imnmunofluorescence with a minimally fluorescent background under control conditions. After alginase treatment, fluorescence of the bacteria and the background (MEP) was substantially decreased in both strains C1900M and LM3M. Alginase treatmnent enhanced phagocytosis of both of these strains. Fluorescence was only minimally decreased after alginase treatment of strain C2146M; phagocytosis of this strain was not enhanced by alginase. Heattreated alginase had little or no effect on the immunofluorescence of any of the three strains. DISCUSSION Alginate-degrading enzymes from different sources have been shown to digest the MEP of mucoid P. aeruginosa (8, 10, 15, 28) . MEP in its native, acetylated form is less susceptible to the action of alginase than when it is deacetylated (15) . Nevertheless, both forms have been shown to be degraded to various degrees by mannuronic acid-specific alginases (8, 15) .
In the current investigation, we showed that an alginase from B. circulans was capable of degrading MEP from four mucoid strains of P. aeruginosa from CF patients. These MEPs were in their native form and were therefore acetylated. Alginase treatment of mucoid P. aeruginosa cells resulted in degradation of the surface MEP of all eight test strains and enhancement of phagocytosis by Mi for five. The enzyme removed the MEP from the bacterial cell surface as measured by a chemical assay (TBA) and immunofluorescence staining of the MEP before and after alginase treatment. The specificity of alginase for digestion of MEP from mucoid P. aeruginosa was examined by using three nonmucoid isolates from the patient from whom strain C1900M was isolated. Neither alginase nor heat-treated alginase enhanced phagocytosis of any of these nonmucoid bacteria compared with phagocytosis of Tris controls, and there was no TBA-positive material released (unpublished data).
Although alginase degraded MEP from the surface of all eight P. aeruginosa strains, phagocytosis was enhanced for only five. This may have been due to differences among strains in the ratio of mannuronic acid to guluronic acid and/ or the degree of acetylation of the different polysaccharides. Mucoid P. aeruginosa strains have been shown to vary in the ratio of the two uronic acid constituents; since 0-acetyl groups are associated only with mannuronic acid residues, the degree of acetylation also varies from strain to strain (22, 23) . MEPs with a higher percentage of mannuronate residues would likely be more richly acetylated and more resistant to alginase degradation.
The quantity of MEP on the surface of bacteria varies among strains, and large amounts of MEP could be more difficult to degrade with alginase. This may explain why three strains resisted phagocytosis even though their MEPs were degraded. Strains C2101M and C2146M produced copious amounts of polysaccharide, as judged by the viscosity of the supernatant after each wash and the difficulty of suspending the bacterial pellets, compared with the other mucoid organisms studied. Both of these strains resisted phagocytosis both before and after alginase treatment. We did not quantitate the amount of MEP or the degree of acetylation of MEP in the organisms tested. Chemical analysis of the MEPs from these strains may provide a better understanding of their relative susceptibilities to enzymatic digestion.
Heat-inactivated crude or partially purified alginase was incapable of degrading the bacterial surface MEP but enhanced phagocytosis by M4 when bacteria were preincubated with the enzyme for 2 h prior to phagocytosis experiments. On the other hand, when heated alginase was added directly to the phagocytic mixture, the results were similar to those for the Tris controls. These results suggest that the enhancement of mucoid P. aeruginosa phagocytosis after treatment with heated alginase is nonspecific. The 2-h incubation of bacteria and alginase perhaps allows these organisms to be coated by the denatured proteins or secreted bacterial products, which may make them susceptible to nonspecific uptake by MP. In fact, preincubation of bacteria with other proteins such as bovine serum albumin also enhances bacterial uptake by M4X to some degree (unpublished data). The heat-inactivated alginase might simply have altered the hydrophobic and/or electrostatic properties of the bacterial surface, thereby enhancing susceptibility to nonopsonic phagocytosis (25) . Nevertheless, the native alginase was superior to the heat-inactivated alginase in enhancing phagocytosis for each of the five strains (P < 0.0001).
The alginase used in this study resembles the mannuronidase from B. circulans JBH2 characterized by Hansen et al. (10) . We have cloned the alginase gene in Escherichia coli, but gene expression is poor (F. Eftekhar, W. Paranchych, and D. P. Speert, Abstr. Annu. Meet. Am. Soc. Microbiol. 1987, B258, p. 67). Other alginases with different specificities (guluronidases versus mannuronidases) may prove to have a wider range of activity against mucoid P. aeruginosa. We are also screening CF isolates of P. aeruginosa for alginase production. It has been found that alginase production is greater in mucoid than in nonmucoid strains of P. aeruginosa (8, 15) . In situ production of alginase by mucoid P. aeruginosa could modulate the severity of CF lung infections by decreasing the mass of MEP in respiratory secretions. Alginase-producing bacteria may therefore prove to be less virulent by being more susceptible to phagocytosis and killing by pulmonary phagocytes.
